Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bardia Nourbakhsh

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 6, 2021
Serious side effects of amantadine: Rethinking the benefits and risks of medications for MS fatigueBardia Nourbakhsh
Therapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf Stüve
Continuum (Minneapolis, Minn.)|June 5, 2019
Multiple Sclerosis Risk Factors and PathogenesisBardia Nourbakhsh, Ellen M Mowry
JAMA Neurology|November 10, 2015
Association Between Glutamate Blockade and Fatigue in Patients With Multiple SclerosisBardia Nourbakhsh, Nisha Revirajan, Emmanuelle Waubant
Multiple Sclerosis and Related Disorders|January 1, 2025
The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrumentChristian Cordano, Emmanuelle Waubant, Bardia Nourbakhsh
Journal of Clinical Neurology (Seoul, Korea)|September 11, 2018
Determining the Etiology of Internuclear Ophthalmoplegia in a Patient with a Cardiac Pacemaker and Complex Neurological PresentationBardia Nourbakhsh, Christian Cordano, William Renthal
Contemporary Clinical Trials|November 9, 2017
Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trialBardia Nourbakhsh, Nisha Revirajan, Emmanuelle Waubant
Frontiers in Psychiatry|January 25, 2024
Design recommendations for studies that evaluate multiple sclerosis fatigue interventionsMahsa Ghajarzadeh, Emmanuelle Waubant, Bardia Nourbakhsh
Frontiers in Neurology|July 14, 2022
The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A ReviewValerie J Block, Riley Bove, Bardia Nourbakhsh
Multiple Sclerosis and Related Disorders|December 11, 2025
Baseline predictors of sustained fatigue onset in multiple sclerosis: A longitudinal survival analysis of the MS PATHS cohortMahsa Ghajarzadeh, Ellen M Mowry, Bardia Nourbakhsh
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 6, 2021
Serious side effects of amantadine: Rethinking the benefits and risks of medications for MS fatigueBardia Nourbakhsh
Therapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf Stüve
Continuum (Minneapolis, Minn.)|June 5, 2019
Multiple Sclerosis Risk Factors and PathogenesisBardia Nourbakhsh, Ellen M Mowry
JAMA Neurology|November 10, 2015
Association Between Glutamate Blockade and Fatigue in Patients With Multiple SclerosisBardia Nourbakhsh, Nisha Revirajan, Emmanuelle Waubant
Multiple Sclerosis and Related Disorders|January 1, 2025
The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrumentChristian Cordano, Emmanuelle Waubant, Bardia Nourbakhsh
Journal of Clinical Neurology (Seoul, Korea)|September 11, 2018
Determining the Etiology of Internuclear Ophthalmoplegia in a Patient with a Cardiac Pacemaker and Complex Neurological PresentationBardia Nourbakhsh, Christian Cordano, William Renthal
Contemporary Clinical Trials|November 9, 2017
Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trialBardia Nourbakhsh, Nisha Revirajan, Emmanuelle Waubant
Frontiers in Psychiatry|January 25, 2024
Design recommendations for studies that evaluate multiple sclerosis fatigue interventionsMahsa Ghajarzadeh, Emmanuelle Waubant, Bardia Nourbakhsh
Frontiers in Neurology|July 14, 2022
The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A ReviewValerie J Block, Riley Bove, Bardia Nourbakhsh
Multiple Sclerosis and Related Disorders|December 11, 2025
Baseline predictors of sustained fatigue onset in multiple sclerosis: A longitudinal survival analysis of the MS PATHS cohortMahsa Ghajarzadeh, Ellen M Mowry, Bardia Nourbakhsh
Pageof 8